Harmonization of CSF and imaging biomarkers for Alzheimer’s disease biomarkers: need and practical applications for genetics studies and preclinical classification

INTRODUCTION: In Alzheimer’s disease (AD) research, cerebrospinal fluid (CSF) Amyloid beta (Aβ), Tau and pTau are the most accepted and well validated biomarkers. Several methods and platforms exist to measure those biomarkers which leads to challenges in combining data across studies. Thus, there i...

Descripción completa

Detalles Bibliográficos
Autores principales: Timsina, Jigyasha, Ali, Muhammad, Do, Anh, Wang, Lihua, Sung, Yun Ju, Cruchaga, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245826/
https://www.ncbi.nlm.nih.gov/pubmed/37292823
http://dx.doi.org/10.1101/2023.05.24.542118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245826/
https://www.ncbi.nlm.nih.gov/pubmed/37292823
http://dx.doi.org/10.1101/2023.05.24.542118

Ejemplares similares